Glenmede Trust’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,028
Closed -$214K 1431
2024
Q2
$214K Sell
4,028
-3,021
-43% -$160K ﹤0.01% 1175
2024
Q1
$578K Buy
+7,049
New +$578K ﹤0.01% 879
2023
Q3
Sell
-25,033
Closed -$417K 1367
2023
Q2
$417K Hold
25,033
﹤0.01% 882
2023
Q1
$417K Sell
25,033
-256
-1% -$4.26K ﹤0.01% 887
2022
Q4
$238K Buy
+25,289
New +$238K ﹤0.01% 1047